Gyre Therapeutics Sets CEO Ying Luo’s Annual Base Salary at $500,000
Bitget2026/10/22 20:07- Gyre Therapeutics entered new employment agreements with CEO Ying Luo and CFO Thomas Eastling on October 16, 2026.
- Luo receives a $500,000 annual base salary, with a target bonus of $150,000 for 2026.
- Eastling receives a $339,066 annual base salary, with a target bonus of $70,000.
- Termination without cause or resignation for good reason triggers base salary paid over six months, COBRA reimbursement and partial accelerated equity vesting.
- Qualifying terminations within three months before or 12 months after a change of control trigger lump-sum salary-and-bonus payments, full equity vesting.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Grayscale Warns Bitcoin’s Lower Volatility Doesn’t Mean Lower Risk

CoreWeave downplays Jensen Huang's departure, says Nvidia remains a key partner
CoreWeave’s Vice President of Strategy stated that the company will continue its partnership with Nvidia, with hundreds or even thousands of layers of business collaboration between the two sides. Nvidia is a vast institution, not reliant on a single individual for its operations. However, this statement failed to boost market sentiment, and CoreWeave’s stock is currently down more than 5% during intraday trading.


Phoenix hits broad gold and copper at old BC mine
